Pharmacotherapy for Status Epilepticus
Status epilepticus (SE) represents the most severe form of epilepsy. It is one of the most common neurologic emergencies, with an incidence of up to 61 per 100,000 per year and an estimated mortality of 20 %. Clinically, tonic-clonic convulsive SE is divided into four subsequent stages: early, estab...
Main Authors: | Trinka, Eugen, Höfler, Julia, Leitinger, Markus, Brigo, Francesco |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer International Publishing
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/ |
Similar Items
-
Efficacy and Safety of Intravenous Valproate for Status Epilepticus: A Systematic Review
by: Trinka, Eugen, et al.
Published: (2014) -
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
by: Höfler, Julia, et al.
Published: (2016) -
Acute Symptomatic Seizures Caused by Electrolyte Disturbances
by: Nardone, Raffaele, et al.
Published: (2016) -
Underestimated Rate of Status Epilepticus according to the Traditional Definition of Status Epilepticus
by: Ong, Cheung-Ter, et al.
Published: (2015) -
Making SENSE - Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry
by: Kellinghaus, Christoph, et al.
Published: (2015)